L P PHARMACY LIMITED
Company number 04503953 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Risk Analysis Report: L P Pharmacy Limited (04503953)
1. Risk Rating: MEDIUM
Justification: While the company maintains positive net assets (£795,368) and a seemingly healthy current ratio, there are significant structural concerns around the dramatic deterioration in cash reserves and an unusually high concentration of debtors representing 92% of current assets. The declining net assets trajectory over multiple years warrants careful monitoring.
2. Key Concerns
Concern 1: Severe Cash Deterioration
Cash has declined from £494,356 (2017) to £29,952 (2024) — a reduction of approximately 94% over seven years. The most recent year alone saw cash fall from £108,416 to £29,952, a 72% decline. For a pharmacy with only £4 in share capital, this sustained cash erosion raises questions about whether the business is generating sufficient operational cash flow or whether funds are being extracted through intercompany channels.
Concern 2: Unsustainable Debtor Concentration
Debtors of £931,979 represent approximately 92% of current assets (£1,008,132). While NHS receivables are standard for dispensing pharmacies and typically carry low credit risk, this level of concentration creates significant vulnerability. Any delay in NHS payments, dispute over prescriptions, or reconciliation issue could immediately impair liquidity given the minimal cash buffer of under £30,000.
Concern 3: Declining Net Assets Trajectory
Net assets have decreased from £813,197 (2022) to £799,133 (2023) to £795,368 (2024), suggesting the company is either making small losses or distributing profits that exceed retained earnings. Over the longer term, net assets grew from approximately £440k (2016) to £813k (2022), so the recent reversal is notable and requires investigation into whether this reflects operational deterioration or deliberate extraction.
3. Positive Indicators
- Established Business: Incorporated in 2002 with over 22 years of operating history, demonstrating longevity in a regulated sector
- Low Gearing: Total liabilities of £204,115 against total assets of £1,008,964 provides substantial asset coverage; long-term liabilities are minimal at £9,232
- Regulatory Standing: Accounts are filed on time with no overdue filings; the company remains Active with no indications of insolvency proceedings
- NHS-Backed Revenue: As a dispensing chemist, the majority of revenue is likely NHS-derived, providing relatively predictable and creditworthy income streams
- Minimal Capital Commitments: Tangible fixed assets are nearly fully depreciated (£832 net book value), suggesting low future capital expenditure requirements
4. Due Diligence Notes
Priority Investigations:
-
Intercompany Relationship with Orina Group Limited: The PSC register shows Orina Group Limited owns over 75% of shares and voting rights. It is essential to determine whether the cash decline is attributable to intercompany transfers, management charges, or dividends paid to the parent entity. Request consolidated accounts or related party transaction disclosures from Orina Group.
-
Debtor Composition and Ageing: Request a detailed aged debtor analysis. Specifically determine what portion relates to NHS receivables versus other debtors. NHS debtors are typically collectible within 30 days; if debtors include significant non-NHS balances or long-outstanding items, the risk profile changes materially.
-
Profit and Loss Trends: The company has filed abridged accounts and has not delivered the income statement to Companies House (permitted under Section 444). Without revenue, cost of sales, or profit figures, it is impossible to assess operational profitability. Request management accounts to understand trading performance.
-
Cash Flow Dynamics: Investigate the drivers behind the cash decline. Specifically, request: - Dividend history and distribution policy - Intercompany payment schedules - Working capital management policies - Any capital expenditure or lease commitments not visible in the abridged accounts
-
Lease and Commitment Details: Tangible fixed assets include "Leased Assets Held as Lessee" under Plant & Machinery. The nature and remaining term of these commitments should be clarified, as should any other off-balance-sheet obligations.
-
Operational Viability at Current Cash Levels: With approximately £30,000 in cash and average employee costs for 4 staff, assess whether the company maintains adequate working capital facilities or overdraft arrangements to manage day-to-day operations.